ArticleAnnals of nuclear medicine2022
Automated semi-quantitative amyloid PET analysis technique without MR images for Alzheimer's disease.
Article in Annals of nuclear medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 27 citations in OpenAlex.
- Quantitative agreement between AMYclz and CortexID forJapanese journal of radiology · 2026Article
- Association of global gray matter volume and cortical thickness with cognitive function stratified by amyloid PET status.Annals of nuclear medicine · 2026Article
- Amyloid-related imaging abnormalities in Japanese patients with Alzheimer's disease treated with Lecanemab: A real-world study.The journal of prevention of Alzheimer's disease · 2026Observational
- ATNIVS biomarker heterogeneity in real-world patients receiving lecanemab.The journal of prevention of Alzheimer's disease · 2026Article
- Comparative evaluation of CortexID and VIZCalc software in brain amyloid PET: a retrospective study of 116 cases.Annals of nuclear medicine · 2026Article
- Comparison of MRI-, CT- and PET-based anatomical standardization for Centiloid scale calculation in [Annals of nuclear medicine · 2026Article
- Higher phosphorylated tau levels predict cognitive decline and amyloid-related imaging abnormalities during lecanemab treatment: clinical practice data.Alzheimer's research & therapy · 2025Article
- Using neuropsychological test scores to predict beta-amyloid deposition in older adults across the late-life cognitive continuum.Journal of clinical and experimental neuropsychology · 2025Article
- Elapsed time changes of the brain radiopharmaceutical accumulation of the amyloid PET examination usingAnnals of nuclear medicine · 2025Article
- Establishing cutoff values for visual amyloid positivity in [EJNMMI research · 2025Article
- Interrater agreement and variability in visual reading of [18F] flutemetamol PET images.Annals of nuclear medicine · 2025Article
- Optimization of penalization function in Bayesian penalized likelihood reconstruction algorithm for [Physical and engineering sciences in medicine · 2024Article
- Quantitative evaluation of striatal uptake ratios using an adaptive template registration method forAnnals of nuclear medicine · 2024Article
- New objective simple evaluation methods of amyloid PET/CT using whole-brain histogram and Top20%-Map.Annals of nuclear medicine · 2024Article
- Comparison of consistency in centiloid scale among different analytical methods in amyloid PET: the CapAIBL, VIZCalc, and Amyquant methods.Annals of nuclear medicine · 2024Article
- Phantom and clinical evaluation of the Bayesian penalised likelihood reconstruction algorithm Q.Clear without PSF correction in amyloid PET images.EJNMMI physics · 2024Article
- Development of software for measuring brain amyloid accumulation usingBrain and behavior · 2023Article
- Clinical utility of LUMIPULSE plasma p-tau217 to identify amyloid positivity among candidates for amyloid-targeting treatments in a real-world cohort.Alzheimer's & dementia (Amsterdam, Netherlands)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
Abstract
objectiveAlthough beta-amyloid (Aβ) positron emission tomography (PET) images are interpreted visually as positive or negative, approximately 10% are judged as equivocal in Alzheimer's disease. Therefore, we aimed to develop an automated semi-quantitative analysis technique using
methodsOverall, 136 cases of patients administered
resultsSUVr calculated by our method and CortexID were highly correlated (R
conclusionsThis semi-quantitative analysis technique using
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.